Amrit Ray

ORCID: 0000-0002-7902-2370 · 2 papers in corpus

article 2006

Subcutaneous Depot Medroxyprogesterone Acetate versus Leuprolide Acetate in the Treatment of Endometriosis-Associated Pain

·doi:10.1097/01.ogx.0000216525.26292.36

This study compared the effectiveness and safety of a new subcutaneous formulation of depot medroxyprogesterone acetate delivering 104 mg per 0.65 mL (DMPA-SC 104) every 3 months with those of leuprolide—a widely used and effective treatmen…

article 2005

Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain

Human Reproduction ·doi:10.1093/humrep/dei290

BACKGROUND: A clinical study compared efficacy and safety of depot medroxyprogesterone acetate (DMPA) with leuprolide for endometriosis-associated pain. METHODS: This multicentre, 18 month, evaluator-blinded, comparator-controlled trial ran…